APO Research

APO RESEARCH · REPORT

Metronidazole Injection

Selected research

Industry Growth & Trends

Global Metronidazole Injection Industry Growth and Trends Forecast to 2032

Market perspective

The global Metronidazole Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metronidazole Injection include Pfizer, Baxter, Unique Pharmaceuticals, Sanofi-Aventis Canada Inc, Sagent Pharmaceuticals, Qatar Pharma, JB Chemicals and Pharmaceuticals, B. Braun Medical Inc and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metronidazole Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metronidazole Injection market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metronidazole Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metronidazole Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metronidazole Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metronidazole Injection Market by Company

Pfizer

Baxter

Unique Pharmaceuticals

Sanofi-Aventis Canada Inc

Sagent Pharmaceuticals

Qatar Pharma

JB Chemicals and Pharmaceuticals

B. Braun Medical Inc

AdvaCare Pharma

Metronidazole Injection Segment by Type

500mg/100mL

50mg/10mL

Metronidazole Injection Segment by Application

Adult Use

Pediatric Use

Geriatric Use

Metronidazole Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metronidazole Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metronidazole Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500mg/100mL Table 2. Major Company of 50mg/10mL Table 3. Global Metronidazole Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Metronidazole Injection Sales by Type (2021-2026) & (K L) Table 5. Global Metronidazole Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Metronidazole Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Metronidazole Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Metronidazole Injection Price by Type (2021-2026) & (US$/L) Table 9. Global Metronidazole Injection Sales by Type (2027-2032) & (K L) Table 10. Global Metronidazole Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Metronidazole Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Metronidazole Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Metronidazole Injection Price by Type (2027-2032) & (US$/L) Table 14. North America Metronidazole Injection Sales by Type (2021-2026) & (K L) Table 15. North America Metronidazole Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Metronidazole Injection Sales by Type (2021-2026) & (K L) Table 17. Europe Metronidazole Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Metronidazole Injection Sales by Type (2021-2026) & (K L) Table 19. Asia-Pacific Metronidazole Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Metronidazole Injection Sales by Type (2021-2026) & (K L) Table 21. Latin America Metronidazole Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Metronidazole Injection Sales by Type (2021-2026) & (K L) Table 23. Middle East and Africa Metronidazole Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Metronidazole Injection Industry Trends Table 25. Metronidazole Injection Industry Drivers Table 26. Metronidazole Injection Industry Opportunities and Challenges Table 27. Metronidazole Injection Industry Restraints Table 28. Global Metronidazole Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Metronidazole Injection Revenue Market Share by Company (2021-2026) Table 30. Global Metronidazole Injection Sales by Company (2021-2026) & (K L) Table 31. Global Metronidazole Injection Sales Share by Company (2021-2026) Table 32. Global Metronidazole Injection Market Price by Company (2021-2026) & (US$/L) Table 33. Global Metronidazole Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Metronidazole Injection Major Company Production Sites and Headquarters Table 35. Global Metronidazole Injection Company, Product Type & Application Table 36. Global Metronidazole Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Metronidazole Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Metronidazole Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Metronidazole Injection Sales by Region (2021-2026) & (K L) Table 41. Global Metronidazole Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Metronidazole Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Metronidazole Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Metronidazole Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 45. Global Metronidazole Injection Sales by Region (2027-2032) & (K L) Table 46. Global Metronidazole Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Metronidazole Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Metronidazole Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Metronidazole Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 50. Global Metronidazole Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Metronidazole Injection Sales by Application (2021-2026) & (K L) Table 52. Global Metronidazole Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Metronidazole Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Metronidazole Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Metronidazole Injection Price by Application (2021-2026) & (US$/L) Table 56. Global Metronidazole Injection Sales by Application (2027-2032) & (K L) Table 57. Global Metronidazole Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Metronidazole Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Metronidazole Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Metronidazole Injection Price by Application (2027-2032) & (US$/L) Table 61. North America Metronidazole Injection Sales by Application (2021-2026) & (K L) Table 62. North America Metronidazole Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Metronidazole Injection Sales by Application (2021-2026) & (K L) Table 64. Europe Metronidazole Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Metronidazole Injection Sales by Application (2021-2026) & (K L) Table 66. Asia-Pacific Metronidazole Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Metronidazole Injection Sales by Application (2021-2026) & (K L) Table 68. Latin America Metronidazole Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Metronidazole Injection Sales by Application (2021-2026) & (K L) Table 70. Middle East and Africa Metronidazole Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 74. Pfizer Metronidazole Injection Product Portfolio Table 75. Pfizer Recent Development Table 76. Baxter Company Information Table 77. Baxter Business Overview Table 78. Baxter Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 79. Baxter Metronidazole Injection Product Portfolio Table 80. Baxter Recent Development Table 81. Unique Pharmaceuticals Company Information Table 82. Unique Pharmaceuticals Business Overview Table 83. Unique Pharmaceuticals Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 84. Unique Pharmaceuticals Metronidazole Injection Product Portfolio Table 85. Unique Pharmaceuticals Recent Development Table 86. Sanofi-Aventis Canada Inc Company Information Table 87. Sanofi-Aventis Canada Inc Business Overview Table 88. Sanofi-Aventis Canada Inc Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 89. Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio Table 90. Sanofi-Aventis Canada Inc Recent Development Table 91. Sagent Pharmaceuticals Company Information Table 92. Sagent Pharmaceuticals Business Overview Table 93. Sagent Pharmaceuticals Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 94. Sagent Pharmaceuticals Metronidazole Injection Product Portfolio Table 95. Sagent Pharmaceuticals Recent Development Table 96. Qatar Pharma Company Information Table 97. Qatar Pharma Business Overview Table 98. Qatar Pharma Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 99. Qatar Pharma Metronidazole Injection Product Portfolio Table 100. Qatar Pharma Recent Development Table 101. JB Chemicals and Pharmaceuticals Company Information Table 102. JB Chemicals and Pharmaceuticals Business Overview Table 103. JB Chemicals and Pharmaceuticals Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 104. JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio Table 105. JB Chemicals and Pharmaceuticals Recent Development Table 106. B. Braun Medical Inc Company Information Table 107. B. Braun Medical Inc Business Overview Table 108. B. Braun Medical Inc Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 109. B. Braun Medical Inc Metronidazole Injection Product Portfolio Table 110. B. Braun Medical Inc Recent Development Table 111. AdvaCare Pharma Company Information Table 112. AdvaCare Pharma Business Overview Table 113. AdvaCare Pharma Metronidazole Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 114. AdvaCare Pharma Metronidazole Injection Product Portfolio Table 115. AdvaCare Pharma Recent Development Table 116. North America Metronidazole Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 117. North America Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 118. North America Metronidazole Injection Sales Market Share by Country (2021-2026) Table 119. North America Metronidazole Injection Sales Forecast by Country (2027-2032) & (K L) Table 120. North America Metronidazole Injection Sales Market Share Forecast by Country (2027-2032) Table 121. North America Metronidazole Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Metronidazole Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Metronidazole Injection Market Share by Country (2021-2026) Table 124. North America Metronidazole Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Metronidazole Injection Market Share Forecast by Country (2027-2032) Table 126. Europe Metronidazole Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 127. Europe Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 128. Europe Metronidazole Injection Sales Market Share by Country (2021-2026) Table 129. Europe Metronidazole Injection Sales Forecast by Country (2027-2032) & (K L) Table 130. Europe Metronidazole Injection Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Metronidazole Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Metronidazole Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Metronidazole Injection Market Share by Country (2021-2026) Table 134. Europe Metronidazole Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Metronidazole Injection Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Metronidazole Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 138. Asia-Pacific Metronidazole Injection Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Metronidazole Injection Sales Forecast by Country (2027-2032) & (K L) Table 140. Asia-Pacific Metronidazole Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Metronidazole Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Metronidazole Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Metronidazole Injection Market Share by Country (2021-2026) Table 144. Asia-Pacific Metronidazole Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Metronidazole Injection Market Share Forecast by Country (2027-2032) Table 146. Latin America Metronidazole Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 147. Latin America Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 148. Latin America Metronidazole Injection Sales Market Share by Country (2021-2026) Table 149. Latin America Metronidazole Injection Sales Forecast by Country (2027-2032) & (K L) Table 150. Latin America Metronidazole Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Metronidazole Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Metronidazole Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Metronidazole Injection Market Share by Country (2021-2026) Table 154. Latin America Metronidazole Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Metronidazole Injection Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Metronidazole Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Metronidazole Injection Sales by Country (2021-2026) & (K L) Table 158. Middle East and Africa Metronidazole Injection Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Metronidazole Injection Sales Forecast by Country (2027-2032) & (K L) Table 160. Middle East and Africa Metronidazole Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Metronidazole Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Metronidazole Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Metronidazole Injection Market Share by Country (2021-2026) Table 164. Middle East and Africa Metronidazole Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Metronidazole Injection Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Metronidazole Injection Distributors List Table 169. Metronidazole Injection Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Metronidazole Injection Image Figure 2. Global Metronidazole Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metronidazole Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Metronidazole Injection Sales (2021-2032) & (K L) Figure 5. 500mg/100mL Image Figure 6. Global 500mg/100mL Sales YoY Growth (2021-2032) & (K L) Figure 7. 50mg/10mL Image Figure 8. Global 50mg/10mL Sales YoY Growth (2021-2032) & (K L) Figure 9. Global Metronidazole Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Metronidazole Injection Market Share by Type 2025 VS 2032 Figure 11. North America Metronidazole Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Metronidazole Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Metronidazole Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Metronidazole Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Metronidazole Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Metronidazole Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Metronidazole Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Metronidazole Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Metronidazole Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Metronidazole Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Metronidazole Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adult Use Image Figure 24. Global Adult Use Sales YoY Growth (2021-2032) & (K L) Figure 25. Pediatric Use Image Figure 26. Global Pediatric Use Sales YoY Growth (2021-2032) & (K L) Figure 27. Geriatric Use Image Figure 28. Global Geriatric Use Sales YoY Growth (2021-2032) & (K L) Figure 29. Global Metronidazole Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Metronidazole Injection Market Share by Application 2025 VS 2032 Figure 31. North America Metronidazole Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Metronidazole Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Metronidazole Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Metronidazole Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Metronidazole Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Metronidazole Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Metronidazole Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Metronidazole Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Metronidazole Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Metronidazole Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Metronidazole Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 42. North America Metronidazole Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Metronidazole Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Metronidazole Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 46. Europe Metronidazole Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Metronidazole Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Metronidazole Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 50. Asia-Pacific Metronidazole Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Metronidazole Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Metronidazole Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 54. Latin America Metronidazole Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Metronidazole Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Metronidazole Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 58. Middle East and Africa Metronidazole Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Metronidazole Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Metronidazole Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Metronidazole Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg/100mL
  • 50mg/10mL
Applications
  • Adult Use
  • Pediatric Use
  • Geriatric Use
Companies covered
  • Pfizer
  • Baxter
  • Unique Pharmaceuticals
  • Sanofi-Aventis Canada Inc
  • Sagent Pharmaceuticals
  • Qatar Pharma
  • JB Chemicals and Pharmaceuticals
  • B. Braun Medical Inc
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metronidazole Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metronidazole Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metronidazole Injection Market by Type
  6. 1.3.1 500mg/100mL
  7. 1.3.2 50mg/10mL
  8. 1.4 Global Metronidazole Injection Market Size by Type
  9. 1.4.1 Global Metronidazole Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Metronidazole Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Metronidazole Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Metronidazole Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Metronidazole Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Metronidazole Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Metronidazole Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Metronidazole Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metronidazole Injection Industry Trends
  2. 2.2 Metronidazole Injection Industry Drivers
  3. 2.3 Metronidazole Injection Industry Opportunities and Challenges
  4. 2.4 Metronidazole Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metronidazole Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Metronidazole Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Metronidazole Injection Price (2021-2026)
  4. 3.4 Global Metronidazole Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metronidazole Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Metronidazole Injection Company, Product Type & Application
  7. 3.7 Global Metronidazole Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metronidazole Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metronidazole Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metronidazole Injection Tier 1, Tier 2, and Tier 3
4 Metronidazole Injection Regional Status and Outlook
  1. 4.1 Global Metronidazole Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metronidazole Injection Historic Market Size by Region
  3. 4.2.1 Global Metronidazole Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metronidazole Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metronidazole Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metronidazole Injection Forecasted Market Size by Region
  7. 4.3.1 Global Metronidazole Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metronidazole Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metronidazole Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metronidazole Injection by Application
  1. 5.1 Metronidazole Injection Market by Application
  2. 5.1.1 Adult Use
  3. 5.1.2 Pediatric Use
  4. 5.1.3 Geriatric Use
  5. 5.2 Global Metronidazole Injection Market Size by Application
  6. 5.2.1 Global Metronidazole Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Metronidazole Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Metronidazole Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Metronidazole Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Metronidazole Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Metronidazole Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Metronidazole Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Metronidazole Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Metronidazole Injection Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Metronidazole Injection Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Unique Pharmaceuticals
  14. 6.3.1 Unique Pharmaceuticals Company Information
  15. 6.3.2 Unique Pharmaceuticals Business Overview
  16. 6.3.3 Unique Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Unique Pharmaceuticals Metronidazole Injection Product Portfolio
  18. 6.3.5 Unique Pharmaceuticals Recent Developments
  19. 6.4 Sanofi-Aventis Canada Inc
  20. 6.4.1 Sanofi-Aventis Canada Inc Company Information
  21. 6.4.2 Sanofi-Aventis Canada Inc Business Overview
  22. 6.4.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio
  24. 6.4.5 Sanofi-Aventis Canada Inc Recent Developments
  25. 6.5 Sagent Pharmaceuticals
  26. 6.5.1 Sagent Pharmaceuticals Company Information
  27. 6.5.2 Sagent Pharmaceuticals Business Overview
  28. 6.5.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sagent Pharmaceuticals Metronidazole Injection Product Portfolio
  30. 6.5.5 Sagent Pharmaceuticals Recent Developments
  31. 6.6 Qatar Pharma
  32. 6.6.1 Qatar Pharma Company Information
  33. 6.6.2 Qatar Pharma Business Overview
  34. 6.6.3 Qatar Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Qatar Pharma Metronidazole Injection Product Portfolio
  36. 6.6.5 Qatar Pharma Recent Developments
  37. 6.7 JB Chemicals and Pharmaceuticals
  38. 6.7.1 JB Chemicals and Pharmaceuticals Company Information
  39. 6.7.2 JB Chemicals and Pharmaceuticals Business Overview
  40. 6.7.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio
  42. 6.7.5 JB Chemicals and Pharmaceuticals Recent Developments
  43. 6.8 B. Braun Medical Inc
  44. 6.8.1 B. Braun Medical Inc Company Information
  45. 6.8.2 B. Braun Medical Inc Business Overview
  46. 6.8.3 B. Braun Medical Inc Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 B. Braun Medical Inc Metronidazole Injection Product Portfolio
  48. 6.8.5 B. Braun Medical Inc Recent Developments
  49. 6.9 AdvaCare Pharma
  50. 6.9.1 AdvaCare Pharma Company Information
  51. 6.9.2 AdvaCare Pharma Business Overview
  52. 6.9.3 AdvaCare Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AdvaCare Pharma Metronidazole Injection Product Portfolio
  54. 6.9.5 AdvaCare Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Metronidazole Injection Sales by Country
  2. 7.1.1 North America Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metronidazole Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Metronidazole Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metronidazole Injection Market Size by Country
  6. 7.2.1 North America Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metronidazole Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Metronidazole Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metronidazole Injection Sales by Country
  2. 8.1.1 Europe Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metronidazole Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Metronidazole Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metronidazole Injection Market Size by Country
  6. 8.2.1 Europe Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metronidazole Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metronidazole Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metronidazole Injection Sales by Country
  2. 9.1.1 Asia-Pacific Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metronidazole Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metronidazole Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metronidazole Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metronidazole Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metronidazole Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metronidazole Injection Sales by Country
  2. 10.1.1 South America Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metronidazole Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Metronidazole Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metronidazole Injection Market Size by Country
  6. 10.2.1 South America Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metronidazole Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Metronidazole Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metronidazole Injection Sales by Country
  2. 11.1.1 Middle East and Africa Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metronidazole Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metronidazole Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metronidazole Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metronidazole Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metronidazole Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metronidazole Injection Value Chain Analysis
  2. 12.1.1 Metronidazole Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metronidazole Injection Production Mode & Process
  7. 12.2 Metronidazole Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metronidazole Injection Distributors
  10. 12.2.3 Metronidazole Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research